newsfilter
← Latest News
Business Wire·

Glaukos to Release Second Quarter 2025 Financial Results after Market Close on July 30

Conference Call and Webcast Scheduled for 1:30 p.m. PT Glaukos Corporation (NYSE:GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal